These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 6384558

  • 1. Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease. Results of a prospective randomized, double-blind, multicenter clinical trial.
    Schuler JJ, Flanigan DP, Holcroft JW, Ursprung JJ, Mohrland JS, Pyke J.
    J Vasc Surg; 1984 Jan; 1(1):160-70. PubMed ID: 6384558
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin E1 treatment of leg ulcers caused by venous or arterial incompetence.
    Beitner H, Hammar H, Olsson AG, Thyresson N.
    Acta Derm Venereol; 1980 Jan; 60(5):425-30. PubMed ID: 6162314
    [Abstract] [Full Text] [Related]

  • 3. Detrimental effect of high-dose prostaglandin E1 in the treatment of ischemic ulcers.
    Rhodes RS, Heard SE.
    Surgery; 1983 Jun; 93(6):839-42. PubMed ID: 6344295
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin E1 in severe lower limb ischaemia: a double-blind controlled trial.
    Telles GS, Campbell WB, Wood RF, Collin J, Baird RN, Morris PJ.
    Br J Surg; 1984 Jul; 71(7):506-8. PubMed ID: 6375799
    [Abstract] [Full Text] [Related]

  • 5. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers.
    Toyota T, Hirata Y, Ikeda Y, Matsuoka K, Sakuma A, Mizushima Y.
    Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621
    [Abstract] [Full Text] [Related]

  • 6. Spontaneous laser doppler flux distribution in ischemic ulcers and the effect of prostanoids: a crossover study comparing the acute action of prostaglandin E1 and iloprost vs saline.
    Gschwandtner ME, Koppensteiner R, Maca T, Minar E, Schneider B, Schnürer G, Ehringer H.
    Microvasc Res; 1996 Jan; 51(1):29-38. PubMed ID: 8812752
    [Abstract] [Full Text] [Related]

  • 7. Prostacyclin treatment of ischemic ulcers and rest pain in unreconstructible peripheral arterial occlusive disease.
    Cronenwett JL, Zelenock GB, Whitehouse WM, Lindenauer SM, Graham LM, Stanley JC.
    Surgery; 1986 Aug; 100(2):369-75. PubMed ID: 3526609
    [Abstract] [Full Text] [Related]

  • 8. [Prostaglandin E1 in stage III and IV arterial occlusive diseases. results of a multicenter study].
    Trübestein G, Ludwig M, Diehm C, Gruss JD, Horsch S.
    Dtsch Med Wochenschr; 1987 Jun 12; 112(24):955-9. PubMed ID: 3297596
    [Abstract] [Full Text] [Related]

  • 9. Prostacyclin for ischemic ulcers in peripheral arterial disease. A random assignment, placebo controlled study.
    Nizankowski R, Królikowski W, Bielatowicz J, Szczeklik A.
    Thromb Res; 1985 Jan 01; 37(1):21-8. PubMed ID: 3885472
    [Abstract] [Full Text] [Related]

  • 10. Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV.
    Creutzig A, Lehmacher W, Elze M.
    Vasa; 2004 Aug 01; 33(3):137-44. PubMed ID: 15461065
    [Abstract] [Full Text] [Related]

  • 11. A controlled study showing significant short term effect of prostaglandin E1 in healing of ischaemic ulcers of the lower limb in man.
    Eklund AE, Eriksson G, Olsson AG.
    Prostaglandins Leukot Med; 1982 Mar 01; 8(3):265-71. PubMed ID: 7043494
    [Abstract] [Full Text] [Related]

  • 12. Intravenous infusion of prostaglandin E1 (PGE1) in management of limb ischemia.
    Sethi GK, Bridgman AH, King L, Scott SM.
    Am Surg; 1986 Sep 01; 52(9):474-8. PubMed ID: 3752724
    [Abstract] [Full Text] [Related]

  • 13. The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery disease.
    Olsson AG, Nilsson E.
    Prostaglandins Med; 1981 Apr 01; 6(4):329-39. PubMed ID: 7025066
    [Abstract] [Full Text] [Related]

  • 14. The effect of ciprostene in patients with peripheral vascular disease (PVD) characterized by ischemic ulcers. The Ciprostene Study Group.
    J Clin Pharmacol; 1991 Jan 01; 31(1):81-7. PubMed ID: 2045533
    [Abstract] [Full Text] [Related]

  • 15. Intra-arterial alprostadil for nonatherosclerotic vasculopathy.
    Wooster DL, Shamess CJ, Madras PN, Keystone EC.
    JAMA; 1981 May 08; 245(18):1846-9. PubMed ID: 7230371
    [Abstract] [Full Text] [Related]

  • 16. Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.
    Belch JJ, McKay A, McArdle B, Leiberman P, Pollock JG, Lowe GD, Forbes CD, Prentice CR.
    Lancet; 1983 Feb 12; 1(8320):315-7. PubMed ID: 6130330
    [Abstract] [Full Text] [Related]

  • 17. [Preliminary results of prostaglandin E1 therapy in peripheral obliterating arteriopathy].
    Pilger E, Juan H.
    Wien Klin Wochenschr; 1983 Apr 15; 95(8):263-6. PubMed ID: 6683910
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic effect of ticlopidine for ischemic leg ulcers.
    Katsumura T.
    Agents Actions Suppl; 1984 Apr 15; 15():167-72. PubMed ID: 6385645
    [No Abstract] [Full Text] [Related]

  • 19. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia.
    Brass EP, Anthony R, Dormandy J, Hiatt WR, Jiao J, Nakanishi A, McNamara T, Nehler M, Circulase investigators.
    J Vasc Surg; 2006 Apr 15; 43(4):752-9. PubMed ID: 16616232
    [Abstract] [Full Text] [Related]

  • 20. Healing of ischaemic ulcers by intravenous prostaglandin E1 in a woman with thrombangitis obliterans.
    Olsson AG, Thyresson N.
    Acta Derm Venereol; 1978 Apr 15; 58(5):467-72. PubMed ID: 82360
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.